---
layout: default
title: Data Sources
nav_order: 93
permalink: /sources/
description: "Data sources behind UsTxGNN: the FDA NDC Directory and Drugs@FDA, TxGNN, ClinicalTrials.gov, PubMed and DrugBank."
---

# Data Sources

<div class="key-takeaway">
Every conclusion traces back to a public data source — nothing is a black box.
</div>

---

<!-- site-data:start（母目錄 .claude/gen_page_data_20261116.py 產生，勿手改）-->
## United States: data behind this site

This site publishes reports for **{{ site.data.drug_stats.total_drugs }}** medicines listed in the registration data of [FDA](https://www.fda.gov/) (United States).

Reports by evidence level:

| Evidence level | Reports | Share |
|---|---|---|
| L1 | {{ site.data.drug_stats.level_counts.L1 }} | {{ site.data.drug_stats.level_counts.L1 | times: 100.0 | divided_by: site.data.drug_stats.total_drugs | round: 1 }}% |
| L2 | {{ site.data.drug_stats.level_counts.L2 }} | {{ site.data.drug_stats.level_counts.L2 | times: 100.0 | divided_by: site.data.drug_stats.total_drugs | round: 1 }}% |
| L3 | {{ site.data.drug_stats.level_counts.L3 }} | {{ site.data.drug_stats.level_counts.L3 | times: 100.0 | divided_by: site.data.drug_stats.total_drugs | round: 1 }}% |
| L4 | {{ site.data.drug_stats.level_counts.L4 }} | {{ site.data.drug_stats.level_counts.L4 | times: 100.0 | divided_by: site.data.drug_stats.total_drugs | round: 1 }}% |
| L5 | {{ site.data.drug_stats.level_counts.L5 }} | {{ site.data.drug_stats.level_counts.L5 | times: 100.0 | divided_by: site.data.drug_stats.total_drugs | round: 1 }}% |
{% assign na = site.data.drug_stats.total_drugs | minus: site.data.drug_stats.level_counts.L1 | minus: site.data.drug_stats.level_counts.L2 | minus: site.data.drug_stats.level_counts.L3 | minus: site.data.drug_stats.level_counts.L4 | minus: site.data.drug_stats.level_counts.L5 %}{% if na > 0 %}| N/A | {{ na }} | {{ na | times: 100.0 | divided_by: site.data.drug_stats.total_drugs | round: 1 }}% |{% endif %}

410 predicted drug–disease pairs on this site appear on no other of the 30 TxGNN sites.

<!-- site-data:end -->

## Source overview

<table class="comparison-table">
<thead>
<tr><th>Type</th><th>Source</th><th>Used for</th></tr>
</thead>
<tbody>
<tr><td>Registration data</td><td><a href="https://www.fda.gov/">FDA</a></td><td>NDC Directory (drug list and ingredients) and Drugs@FDA (marketing status) for the United States</td></tr>
<tr><td>Prediction model</td><td><a href="https://zitniklab.hms.harvard.edu/projects/TxGNN/">TxGNN</a></td><td>Drug&ndash;disease association prediction</td></tr>
<tr><td>Clinical trials</td><td><a href="https://clinicaltrials.gov/">ClinicalTrials.gov</a></td><td>Evidence grading (NCT)</td></tr>
<tr><td>Literature</td><td><a href="https://pubmed.ncbi.nlm.nih.gov/">PubMed</a></td><td>Evidence grading (PMID)</td></tr>
<tr><td>Drug information</td><td><a href="https://go.drugbank.com/">DrugBank</a></td><td>Ingredient mapping and target data</td></tr>
<tr><td>Interactions</td><td><a href="https://ddinter2.scbdd.com/">DDInter</a></td><td>Drug&ndash;drug interaction data</td></tr>
</tbody>
</table>

---

## United States medicine data

| Item | Detail |
|------|--------|
| Drug list | FDA National Drug Code (NDC) Directory: <https://www.accessdata.fda.gov/cder/ndctext.zip> |
| Marketing status | Drugs@FDA full file via openFDA: <https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip> |
| Publisher | U.S. Food and Drug Administration (FDA) |
| Update | The Drugs@FDA file is downloaded again every Monday by an automated workflow; NDA / ANDA / BLA applications whose products are all discontinued are marked as discontinued in drug reports |

---

## Licensing

Each source has its own licence — please check before citing:

- **TxGNN**: academic use; cite Huang et al. (2024)
- **ClinicalTrials.gov / PubMed**: US NIH public data
- **DrugBank**: non-commercial use subject to its licence terms
- **FDA NDC Directory / Drugs@FDA (openFDA)**: published by the U.S. FDA; check the openFDA terms of service before reuse

---

## Update frequency

| Data | Frequency |
|------|-----------|
| Drugs@FDA marketing status | Weekly (every Monday, automated) |
| Trial / literature evidence | Re-collected periodically |
| Interaction data | Reviewed quarterly |

---

## Academic citation

> Huang, K., et al. (2024). A foundation model for clinician-centered drug repurposing. *Nature Medicine*.
> [DOI: 10.1038/s41591-024-03233-x](https://doi.org/10.1038/s41591-024-03233-x)

---

## About the Developer

This platform is developed and operated by **藥提醒科技有限公司** (yao.care). See the
<a href="{{ '/about/' | relative_url }}">About</a> page for the full company and methodology background.

---

<div class="disclaimer">
<strong>Disclaimer</strong><br>
This report is for academic research reference only and <strong>does not constitute medical advice</strong>. Always follow your physician's instructions; never adjust medication on your own. Any drug repurposing decision requires full clinical validation and regulatory review.
<br><br>
<small>Reviewed by: 藥提醒科技有限公司 (yao.care)</small>
</div>
